Distribution of NOD2, ATG16L1, IRGM, CARD9 and ORMDL3 risk alleles and clinical characteristics in ileal CD, colitis and non-IBD subjects in batches 1 and 2.

The percent of subjects recruited at each of the three IBD centers with complete genotype and clinical characteristics with at least one risk allele and the percent of subjects who have at least one risk allele (see Methods) are listed.